Skye Bioscience

SKYE

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-30.19M

EBITDA$-25.51M

EBIT$-25.81M

Pre-tax Income$-57.33M

Net Income$-26.57M

Net Cash$2.02M

Cash Equivalent$80.13M

Total Debt$2.64M

Net Debt$621.72K

Book Value$73.91M

Net Cash Per Share0.06

Book Value Per Share2.53

Return on Equity (ROE)-38.98%

Return on Assets (ROA)-36.51%

Return on Invested Capital (ROI)-38.98%

Net Profit Margin0.00%

Current Ratio16.32

Quick Ratio16.28

Long-Term Debt / Equity0.00